Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Sastry

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Mbio|August 29, 2024
Diagnosis and mitigation of the systemic impact of genome reduction in <i>Escherichia coli</i> DGF-298Antoine Champie, Jean-Christophe Lachance, Anand Sastry, et al.
The British Journal of Radiology|April 26, 2025
Safety and Efficacy of Aneurysms Treated with Endovascular Devices (SEATED)Ahmed R Bassiouny, Anand Sastry, Alex Mortimer, et al.
Journal of Neurointerventional Surgery|December 10, 2023
Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study)Thomas C Booth, Ahmed Bassiouny, Jeremy Lynch, et al.
Nature Biotechnology|February 20, 2018
Recon3D enables a three-dimensional view of gene variation in human metabolismElizabeth Brunk, Swagatika Sahoo, Daniel C Zielinski, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Mbio|August 29, 2024
Diagnosis and mitigation of the systemic impact of genome reduction in <i>Escherichia coli</i> DGF-298Antoine Champie, Jean-Christophe Lachance, Anand Sastry, et al.
The British Journal of Radiology|April 26, 2025
Safety and Efficacy of Aneurysms Treated with Endovascular Devices (SEATED)Ahmed R Bassiouny, Anand Sastry, Alex Mortimer, et al.
Journal of Neurointerventional Surgery|December 10, 2023
Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study)Thomas C Booth, Ahmed Bassiouny, Jeremy Lynch, et al.
Nature Biotechnology|February 20, 2018
Recon3D enables a three-dimensional view of gene variation in human metabolismElizabeth Brunk, Swagatika Sahoo, Daniel C Zielinski, et al.
Pageof 3